fda eases adhd drugs heart-disease concerns
the u.s. drugs regulator said it was not recommending changes in the use of stimulants such as adderall xr and ritalin to treat hyperactivity, after a review of a study into potential heart disease risks from the drugs.
http://feeds.reuters.com/~r/reuters/healthnews/~3/vy7xoj28wrw/us-fda-adhd-idustre7371wo20110408
4811
08 Apr 2011 12:39:01
reuters
health